BEAT
Heartbeam IncNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$49.31M
P/E Ratio
—
EPS
$-0.62
Beta
-0.64
52W High
$4.00
52W Low
$0.54
50-Day MA
$1.38
200-Day MA
$1.52
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Heartbeam Inc
BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-21.10M |
| Operating Margin | 0.00% |
| Return on Equity | -987.00% |
| Return on Assets | -289.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.07 |
| Price-to-Book | 18.78 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -3.00 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $41.09M |
| Float | $33.90M |
| % Insiders | 19.95% |
| % Institutions | 11.11% |
Analyst Ratings
Consensus ($5.08 target)
1
Strong Buy3
BuyData last updated: 4/7/2026